Renters May Age Faster Than Homeowners, Study Finds
WEDNESDAY, Oct. 11, 2023 (HealthDay News) — Renting a home, rather than owning it outright, may speed up the body’s aging process, a new study suggests.Researchers found that when compared with people who owned their home outright (no mortgage), thos…
Learn MoreASTRO: Hypofractionation Effective for Radiotherapy After Breast Reconstruction
WEDNESDAY, Oct. 11, 2023 (HealthDay News) — For women undergoing implant-based breast reconstruction after a mastectomy, use of shorter radiotherapy (RT) courses (hypofractionation) is as effective as conventionally fractionated (CF) RT, according to…
Learn MoreASTRO: Liquid Biopsy Can Stratify Risk in Oligometastatic NSCLC
WEDNESDAY, Oct. 11, 2023 (HealthDay News) — Liquid biopsy, which identifies circulating tumor DNA (ctDNA), performed before radiotherapy (RT) can stratify risk for oligometastatic non-small cell lung cancer (NSCLC) patients, according to a study publ…
Learn MoreBlack Children With Asthma More Likely to Receive Bronchodilators From EMS
WEDNESDAY, Oct. 11, 2023 (HealthDay News) — Black children receiving emergency medical services (EMS) care are more likely to receive a bronchodilator than White children, according to a study published online Sept. 25 in Prehospital Emergency Care.S…
Learn MoreModel Developed for Prioritizing Patients Waiting for Lung Transplant
WEDNESDAY, Oct. 11, 2023 (HealthDay News) — A new model has been developed for prioritizing patients waiting for a lung transplant, according to a study published online Sept. 29 in the American Journal of Respiratory and Critical Care Medicine.Jarro…
Learn MoreHigh-Risk Patients Awaiting Liver Transplant Benefit Most From Living Donors
WEDNESDAY, Oct. 11, 2023 (HealthDay News) — High-risk cirrhosis patients awaiting liver transplant (LT) most benefit from potential living donors, according to a study published online Sept. 2 in Aging.Fakhar Ali Qazi Arisar, M.B.B.S., from the Unive…
Learn MoreNovel Potassium Channel Opener Safe, Effective for Adults With Focal Epilepsy
WEDNESDAY, Oct. 11, 2023 (HealthDay News) — XEN1101 appears safe and effective for the treatment of focal-onset seizures (FOSs), according to results of a phase 2b study published online Oct. 9 in JAMA Neurology.Jacqueline A. French, M.D., from the N…
Learn More